The impact of hypoxia on B cells in COVID-19
Prasanti Kotagiri, Federica Mescia, Aimee Hanson, Lorinda Turner, Laura Bergamaschi, Ana Peñalver, Nathan Richoz, Stephen D Moore, Brian M Ortmann, Benjamin J. Dunmore, View ORCID ProfileHelene Ruffieux, Michael D Morgan, Zewen Kelvin Tuong, Rachael J M Bashford-Rogers, Myra Hosmillo, Stephen Baker, Anne Elmer, Ian G Goodfellow, View ORCID ProfileRavindra K. Gupta, Nathalie Kingston, Paul J. Lehner, Nicholas J. Matheson, Sylvia Richardson, Caroline Saunders, View ORCID ProfileMichael P. Weekes, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Berthold Göttgens, Mark Toshner, Christoph Hess, Patrick. H. Maxwell, Menna. R. Clatworthy, James A. Nathan, John R. Bradley, Paul A. Lyons, Natalie Burrows, Kenneth G.C. Smith
doi: https://doi.org/10.1101/2021.07.12.21260360
Prasanti Kotagiri
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Federica Mescia
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Aimee Hanson
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Lorinda Turner
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Laura Bergamaschi
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Ana Peñalver
3Cambridge Institute for Medical Research, Department of Medicine, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge
Nathan Richoz
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
4Cellular Genetics, Wellcome Sanger Institute, Hinxton. UK
Stephen D Moore
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Brian M Ortmann
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Benjamin J. Dunmore
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Helene Ruffieux
5MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK
Michael D Morgan
6Cancer Research UK – Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK
7Mike Morgan: Need to add: EMBL-EBI, Wellcome Genome Campus, Hinxton, UK
Zewen Kelvin Tuong
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
4Cellular Genetics, Wellcome Sanger Institute, Hinxton. UK
Rachael J M Bashford-Rogers
8Nuffield Department of Medicine, Wellcome Centre for Human Genetics, Oxford, UK
Myra Hosmillo
9Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
Stephen Baker
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Anne Elmer
10NIHR Cambridge Clinical Research Facility, Cambridge Clinical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
Ian G Goodfellow
9Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
Ravindra K. Gupta
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Nathalie Kingston
11Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
12NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
Paul J. Lehner
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Nicholas J. Matheson
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
13NHS Blood and Transplant, Cambridge, UK
Sylvia Richardson
5MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK
Caroline Saunders
10NIHR Cambridge Clinical Research Facility, Cambridge Clinical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
Michael P. Weekes
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Berthold Göttgens
14Department of Haematology, Wellcome & MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK
Mark Toshner
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
15Heart and Lung Research Institute, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
16Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
Christoph Hess
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
17Department of Biomedicine, University and University Hospital Basel, 4031Basel, Switzerland
18Botnar Research Centre for Child Health (BRCCH) University Basel & ETH Zurich, 4059 Basel, Switzerland
Patrick. H. Maxwell
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
3Cambridge Institute for Medical Research, Department of Medicine, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge
Menna. R. Clatworthy
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
4Cellular Genetics, Wellcome Sanger Institute, Hinxton. UK
James A. Nathan
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
John R. Bradley
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
12NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
Paul A. Lyons
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Natalie Burrows
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
3Cambridge Institute for Medical Research, Department of Medicine, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge
Kenneth G.C. Smith
1Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
2Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK
Data Availability
The dataset from our study can be explored interactively through a web portal: https://covid19cellatlas.org.
Posted July 15, 2021.
The impact of hypoxia on B cells in COVID-19
Prasanti Kotagiri, Federica Mescia, Aimee Hanson, Lorinda Turner, Laura Bergamaschi, Ana Peñalver, Nathan Richoz, Stephen D Moore, Brian M Ortmann, Benjamin J. Dunmore, Helene Ruffieux, Michael D Morgan, Zewen Kelvin Tuong, Rachael J M Bashford-Rogers, Myra Hosmillo, Stephen Baker, Anne Elmer, Ian G Goodfellow, Ravindra K. Gupta, Nathalie Kingston, Paul J. Lehner, Nicholas J. Matheson, Sylvia Richardson, Caroline Saunders, Michael P. Weekes, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Berthold Göttgens, Mark Toshner, Christoph Hess, Patrick. H. Maxwell, Menna. R. Clatworthy, James A. Nathan, John R. Bradley, Paul A. Lyons, Natalie Burrows, Kenneth G.C. Smith
medRxiv 2021.07.12.21260360; doi: https://doi.org/10.1101/2021.07.12.21260360
The impact of hypoxia on B cells in COVID-19
Prasanti Kotagiri, Federica Mescia, Aimee Hanson, Lorinda Turner, Laura Bergamaschi, Ana Peñalver, Nathan Richoz, Stephen D Moore, Brian M Ortmann, Benjamin J. Dunmore, Helene Ruffieux, Michael D Morgan, Zewen Kelvin Tuong, Rachael J M Bashford-Rogers, Myra Hosmillo, Stephen Baker, Anne Elmer, Ian G Goodfellow, Ravindra K. Gupta, Nathalie Kingston, Paul J. Lehner, Nicholas J. Matheson, Sylvia Richardson, Caroline Saunders, Michael P. Weekes, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Berthold Göttgens, Mark Toshner, Christoph Hess, Patrick. H. Maxwell, Menna. R. Clatworthy, James A. Nathan, John R. Bradley, Paul A. Lyons, Natalie Burrows, Kenneth G.C. Smith
medRxiv 2021.07.12.21260360; doi: https://doi.org/10.1101/2021.07.12.21260360
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)